Skip to main content
. 2022 Dec 7;56(9):1203–1214. doi: 10.1007/s11094-022-02778-w

Table 5.

Repurposed Drugs Approved for Both Common and Orphan Diseases [4]

Compound Common Disease Orphan Disease Approval Status
Azathioprine Rheumatoid arthritis Renal transplant Approved
Bleomycin Various cancers Pleural effusion Approved
Colchicine Gout Mediterranean fever Approved
Cycloserine Urinary tract infection Tuberculosis Approved
Eflornithine Unwanted facial hair Sleeping sickness Approved
Cyclosporine Rheumatoid arthritis Psoriasis Transplant rejection Approved
Everolimus Renal cancer Renal transplant Approved
Histrelin Prostate cancer Precocious puberty Approved
Interferon alpha Hepatitis B and C Various cancers Approved
Rituximab Rheumatoid arthritis Various cancers Approved
Infliximab Ulcerative colitis Rheumatoid arthritis Psoriasis Crohn’s disease Approved